Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey J Sutherland

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|June 9, 2006
Dependence of molecular properties on proteomic family for marketed oral drugsMichal Vieth, Jeffrey J Sutherland
Journal of Computer-Aided Molecular Design|December 15, 2004
Three-dimensional quantitative structure-activity and structure-selectivity relationships of dihydrofolate reductase inhibitorsJeffrey J Sutherland, Donald F Weaver
Journal of Chemical Information and Computer Sciences|May 28, 2003
Development of quantitative structure-activity relationships and classification models for anticonvulsant activity of hydantoin analoguesJeffrey J Sutherland, Donald F Weaver
Journal of Medicinal Chemistry|October 16, 2004
A comparison of methods for modeling quantitative structure-activity relationshipsJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Journal of Medicinal Chemistry|July 9, 2004
Pruned receptor surface models and pharmacophores for three-dimensional database searchingJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Journal of Chemical Information and Computer Sciences|November 25, 2003
Spline-fitting with a genetic algorithm: a method for developing classification structure-activity relationshipsJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Biochimica Et Biophysica Acta|January 22, 2013
What general conclusions can we draw from kinase profiling data sets?Jeffrey J Sutherland, Cen Gao, Suntara Cahya, et al.
Current Opinion in Drug Discovery & Development|April 23, 2008
Prioritizing hits from phenotypic high-content screensJonathan Low, Louis Stancato, Jonathan Lee, et al.
Nature Communications|July 19, 2023
A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugsJeffrey J Sutherland, Dimitar Yonchev, Alexander Fekete, et al.
Journal of Medicinal Chemistry|April 5, 2008
Chemical fragments as foundations for understanding target space and activity predictionJeffrey J Sutherland, Richard E Higgs, Ian Watson, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|June 9, 2006
Dependence of molecular properties on proteomic family for marketed oral drugsMichal Vieth, Jeffrey J Sutherland
Journal of Computer-Aided Molecular Design|December 15, 2004
Three-dimensional quantitative structure-activity and structure-selectivity relationships of dihydrofolate reductase inhibitorsJeffrey J Sutherland, Donald F Weaver
Journal of Chemical Information and Computer Sciences|May 28, 2003
Development of quantitative structure-activity relationships and classification models for anticonvulsant activity of hydantoin analoguesJeffrey J Sutherland, Donald F Weaver
Journal of Medicinal Chemistry|October 16, 2004
A comparison of methods for modeling quantitative structure-activity relationshipsJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Journal of Medicinal Chemistry|July 9, 2004
Pruned receptor surface models and pharmacophores for three-dimensional database searchingJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Journal of Chemical Information and Computer Sciences|November 25, 2003
Spline-fitting with a genetic algorithm: a method for developing classification structure-activity relationshipsJeffrey J Sutherland, Lee A O'Brien, Donald F Weaver
Biochimica Et Biophysica Acta|January 22, 2013
What general conclusions can we draw from kinase profiling data sets?Jeffrey J Sutherland, Cen Gao, Suntara Cahya, et al.
Current Opinion in Drug Discovery & Development|April 23, 2008
Prioritizing hits from phenotypic high-content screensJonathan Low, Louis Stancato, Jonathan Lee, et al.
Nature Communications|July 19, 2023
A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugsJeffrey J Sutherland, Dimitar Yonchev, Alexander Fekete, et al.
Journal of Medicinal Chemistry|April 5, 2008
Chemical fragments as foundations for understanding target space and activity predictionJeffrey J Sutherland, Richard E Higgs, Ian Watson, et al.
Pageof 4